KTTA Price Target 2026
Pasithea Therapeutics Corp - Analyst target prices & consensus estimates
Current Price
$0.74
Analysts
0
Get Complete KTTA Analysis
AI insights, DCF valuation, financials, and real-time data
View Full AnalysisFrequently Asked Questions
What is the KTTA price target?
Price target data for KTTA is being updated. Wall Street analysts regularly publish price targets based on fundamental analysis and valuation models.
What is the highest KTTA price target?
High price target estimates for KTTA are available from analyst reports and research notes.
What is the lowest KTTA price target?
Low price target estimates for KTTA are published by Wall Street analysts covering the stock.
How accurate are KTTA price targets?
Analyst price targets for KTTA are estimates based on financial models and assumptions. While analysts have access to management and conduct thorough research, price targets should be one of many factors in your investment decision. Market conditions, company execution, and unforeseen events can impact actual stock performance.
How often are KTTA price targets updated?
Analysts update KTTA price targets throughout the year, typically after earnings reports, major company announcements, or significant market events. Some analysts may revise targets quarterly while others update as needed based on new information.
What is the KTTA median price target?
Median price target for KTTA is calculated from all analyst estimates and available on our dashboard.
Should I buy KTTA based on price targets?
Review analyst price targets for KTTA along with other fundamental and technical factors before making investment decisions.
What factors influence KTTA price targets?
Analysts set KTTA price targets based on factors including revenue growth projections, profit margins, competitive position, market share, management execution, industry trends, macroeconomic conditions, and valuation multiples relative to peers. Changes in these factors can lead to price target revisions.